Onderneming Cullinan Therapeutics, Inc.
Aandelen
CGEM
US2300311063
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
16,42 USD | -5,47% |
|
-2,32% | +61,14% |
02/06 | Transcript : Cullinan Therapeutics, Inc. - Special Call | |
01/06 | Cullinan Therapeutics, Inc. Kondigt positieve eerste gegevens aan van de Pivotal Fase 2b Rezil1-studie met Zipalertinib | CI |
Vakgebied
Aantal werknemers: 85
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 18-10-21 |
Jeffrey Jones
CTO | Chief Tech/Sci/R&D Officer | 53 | 28-02-22 |
Jacquelyn Sumer
CMP | Compliance Officer | 46 | 15-08-22 |
Chief Tech/Sci/R&D Officer | 57 | 01-01-18 | |
Kevin Johnston
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-22 |
Chad Messer
IRC | Investor Relations Contact | - | 01-03-22 |
Corinne Savill
PRN | Corporate Officer/Principal | 64 | 01-02-17 |
Stephen Andre
HRO | Human Resources Officer | 62 | 01-04-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 71 | 01-08-17 | |
Thomas Ebeling
BRD | Director/Board Member | 65 | 01-08-17 |
Stephen Webster
BRD | Director/Board Member | 63 | 01-09-20 |
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 18-10-21 |
Director/Board Member | 52 | 01-03-22 | |
David Ryan
BRD | Director/Board Member | 57 | 01-11-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 57 634 234 | 55 017 016 ( 95,46 %) | 0 | 95,46 % |
Bedrijfsgegevens
![Adres Cullinan Therapeutics, Inc.(CGEM)](https://cdn.zonebourse.com/static/address/117317644.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+61,14% | 946 mln. | |
+38,36% | 52,73 mld. | |
+36,73% | 39 mld. | |
-8,63% | 38,52 mld. | |
+25,46% | 30,38 mld. | |
-11,17% | 26,39 mld. | |
+11,44% | 26,08 mld. | |
+45,09% | 14,15 mld. | |
+32,93% | 12,6 mld. | |
-5,30% | 11,51 mld. |
- Beurs
- Aandelen
- Koers CGEM
- Onderneming Cullinan Therapeutics, Inc.